目次


Nature Biotechnology 20th Anniversary

Nature Biotechnology is 20! We have brought together a collection of Features celebrating two decades of the science and business of biotech, with an eye on the future.

Top

In This Issue

In this issue pvii

doi:10.1038/nbt.3518


Top

Editorial

世間に働きかけよう
Breaking out of the bubble p213

doi:10.1038/nbt.3517

The biotech community has made remarkable progress over the past 20 years. Now it needs to break out of its bubble.


免疫プロファイル解析企業が抗がん剤開発の支援へ加速
Immune profiling players shift gear to guide cancer drug development pp215 - 216

Michael Eisenstein

doi:10.1038/nbt0316-215


薬剤開発企業がRAS研究に再注目
Drug developers refocus efforts on RAS pp217 - 218

Cormac Sheridan

doi:10.1038/nbt0316-217


ナチュラルキラー細胞ががんの免疫療法へ
Natural killer cells blaze into immuno-oncology pp219 - 220

Ken Garber

doi:10.1038/nbt0316-219


FDA長官Robert Califfを承認
FDA head Califf spurned p220

doi:10.1038/nbt0316-220a


米国から締め出された食用GMサケ
GM salmon shut out of US p220

doi:10.1038/nbt0316-220b


GMカでジカウイルスに最初の攻撃
GM mosquitoes fire first salvo against Zika virus pp221 - 222

Emily Waltz

doi:10.1038/nbt0316-221


ビアウ社の事故でFAAHに疑念
Bial incident raises FAAH suspicions p223

Eva von Schaper

doi:10.1038/nbt0316-223a


種子スパイが罪状を認める
Seed spy pleads guilty p223

Emily Waltz

doi:10.1038/nbt0316-223b


サノフィ社、マンカインド社の吸入型インスリン製剤を断念
Sanofi drops MannKind's inhaled insulin p224

Mark Ratner

doi:10.1038/nbt0316-224


世界の1カ月
Around the world in a month p225

doi:10.1038/nbt0316-225


Top

Bioentrepreneur

Building a business

Aligning needs pp226 - 230

Dennis Ford & William Kohlbrenner

doi:10.1038/nbt.3497

The best way for aspiring entrepreneurs to achieve their financing goals is to understand what investors and partners want.


Top

Opinion and Comment

Correspondence

Deciphering the EU clinical trials regulation pp231 - 233

Mohamed Abou-El-Enein & Christian K Schneider

doi:10.1038/nbt.3492


A call for industry to embrace green biopharma pp234 - 235

Kristi L Budzinski, Stefan G Koenig, Deborah A O'Connor & Tse-Sung Wu

doi:10.1038/nbt.3493


Marketplace response to GM animal products pp236 - 238

Damien Mather, Rasmus Vikan & John Knight

doi:10.1038/nbt.3494


Commentary

慢性疾患に立ち向かうデジタル医学
Digital medicine's march on chronic disease pp239 - 246

Joseph C Kvedar, Alexander L Fogel, Eric Elenko & Daphne Zohar

doi:10.1038/nbt.3495

Digital medicine offers the possibility of continuous monitoring, behavior modification and personalized interventions at low cost, potentially easing the burden of chronic disease in cost-constrained healthcare systems.


Top

Features

米国経済へのバイオテクノロジー業界の寄与
Estimating the biotech sector's contribution to the US economy pp247 - 255

Robert Carlson

doi:10.1038/nbt.3491

US biotech sector revenue is estimated to have grown on average >10% each year over the past decade—much faster than the rest of the economy. A more comprehensive assessment of biotech's economic contribution, however, will require improved data collection, classification and analysis.


Nature Biotechnologyの研究ツールの20年
20 years of Nature Biotechnology research tools pp256 - 261

Anna Azvolinsky, Laura DeFrancesco, Emily Waltz & Sarah Webb

doi:10.1038/nbt.3507

Authors of some of the most highly cited Nature Biotechnology papers that describe research tools discuss their work and challenges for their fields.


Nature Biotechnologyの生物医学研究の20年
20 years of Nature Biotechnology biomedical research pp262 - 266

Anna Azvolinsky, Charles Schmidt, Emily Waltz & Sarah Webb

doi:10.1038/nbt.3509

Authors of some of the most highly cited Nature Biotechnology biomedical papers from the past 20 years discuss their work and challenges for their fields.


Nature Biotechnologyのバイオエンジニアリング研究の20年
20 years of Nature Biotechnology bioengineering research pp267 - 269

Laura DeFrancesco, Charles Schmidt & Emily Waltz

doi:10.1038/nbt.3508

Authors of some of the most highly cited Nature Biotechnology nonbiomedical papers from the past 20 years discuss their work and challenges for their fields.


バイオテクノロジー研究者の声
Voices of biotech pp270 - 275

Ido Amit, David Baker, Roger Barker, Bonnie Berger, Carolyn Bertozzi, Sangeeta Bhatia, Alessandra Biffi, Francesca Demichelis, Jennifer Doudna, Steven F Dowdy, Drew Endy, Moritz Helmstaedter, Howard Junca, Carl June, Sasha Kamb, Anastasia Khvorova, Dae-hyeong Kim, Jin-Soo Kim, Yamuna Krishnan, Melike Lakadamyali, Tuuli Lappalainen, Sharon Lewin, James Liao, Nick Loman, Emma Lundberg, Lee Lynd, Cathie Martin, Ira Mellman, Atsushi Miyawaki, Christine Mummery, Karen Nelson, Jeanne Paz, Pamela Peralta-Yahya, Paola Picotti, Kornelia Polyak, Kristala Prather, Jun Qin, Stephen Quake, Aviv Regev, John A Rogers, Reshma Shetty, Morten Sommer, Molly Stevens, Gustavo Stolovitzky, Masayo Takahashi, Fuchou Tang, Sarah Teichmann, Maria-Elena Torres-Padilla, Leena Tripathi, Praveen Vemula, Greg Verdine, Frank Vollmer, Jun Wang, Jackie Y Ying, Feng Zhang & Tian Zhang

doi:10.1038/nbt.3502

Nature Biotechnology asks a selection of researchers about the most exciting frontier in their field and the most needed technologies for advancing knowledge and applications.


関係者による未来予測
Community crystal gazing pp276 - 283

Anu Acharya, Kate Bingham, Jay Bradner, Wylie Burke, R Alta Charo, Joel Cherry, André Choulika, Tony Coles, Robert Cook-Deegan, Stanley T Crook, Emilia Díaz, Brent Erickson, L Val Giddings, Sebastian Eriksson Giwa, James C Greenwood, Vishal Gulati, Sam Hall, John Harris, Jamie Heywood, Colin Hill, Jeremy Levin, Adina Mangubat, John Maraganore, Giovanni Mariggi, Barbara J Mazur, Amy L McGuire, Nathalie Moll, Jonathan Moreno, Gail Naughton, Lita Nelsen, Jane Osbourn, Daniel Perez, John Reed, Eric Schmidt, Vicki Seyfert-Margolis, Paul Stoffels, Jørgen Thorball, Tara O'Toole, Indrek Vainu, Sander van Deventer, Elias Zerhouni & Daphne Zohar

doi:10.1038/nbt.3515

A selection of individuals from the biotech ecosystem give their views on the challenges facing the sector over the coming years.


バイオテクノロジーのつまずき
When biotech goes bad pp284 - 291

John Hodgson

doi:10.1038/nbt.3510

A look at 20 years of the dark side of biotech.


Patents

The changing life science patent landscape pp292 - 294

Arti K Rai & Jacob S Sherkow

doi:10.1038/nbt.3504

What have we learned from 20 tumultuous years of patent law in the life sciences? Is patenting likely to be as important for the industry in the future?


Top

News and Views

臨床イメージングから3Dプリンティング組織の移植へ
From clinical imaging to implantation of 3D printed tissues pp295 - 296

E Thomas Pashuck & Molly Stevens

doi:10.1038/nbt.3503

Mechanically stable bone, cartilage and muscle tissues are printed in custom shapes.

See also: Research by Kang et al.


しずくの中のハプロタイプ
Haplotypes drop by drop pp296 - 298

Jacob O Kitzman

doi:10.1038/nbt.3500

Short-read sequencing provides haplotype information when long DNA fragments are barcoded in microfluidic droplets.

See also: Research by Zheng et al.


オフターゲット部位へのグリップを緩めるCas9
Cas9 loosens its grip on off-target sites pp298 - 299

Christopher E Nelson & Charles A Gersbach

doi:10.1038/nbt.3501

Two new variants of the Cas9 nuclease have minimal activity at off-target DNA sites.


Research Highlights p299

doi:10.1038/nbt.3499


Top

Research

Analysis

数千件のショートリード配列解読実験の高速検索
Fast search of thousands of short-read sequencing experiments pp300 - 302

Brad Solomon & Carl Kingsford

doi:10.1038/nbt.3442


Articles

ハイスループットな関連リード配列解読による生殖細胞系列およびがんのゲノムのハプロタイプ解析
Haplotyping germline and cancer genomes with high-throughput linked-read sequencing pp303 - 311

Grace X Y Zheng, Billy T Lau, Michael Schnall-Levin, Mirna Jarosz, John M Bell, Christopher M Hindson, Sofia Kyriazopoulou-Panagiotopoulou, Donald A Masquelier, Landon Merrill, Jessica M Terry, Patrice A Mudivarti, Paul W Wyatt, Rajiv Bharadwaj, Anthony J Makarewicz, Yuan Li, Phillip Belgrader, Andrew D Price, Adam J Lowe, Patrick Marks, Gerard M Vurens, Paul Hardenbol, Luz Montesclaros, Melissa Luo, Lawrence Greenfield, Alexander Wong, David E Birch, Steven W Short, Keith P Bjornson, Pranav Patel, Erik S Hopmans, Christina Wood, Sukhvinder Kaur, Glenn K Lockwood, David Stafford, Joshua P Delaney, Indira Wu, Heather S Ordonez, Susan M Grimes, Stephanie Greer, Josephine Y Lee, Kamila Belhocine, Kristina M Giorda, William H Heaton, Geoffrey P McDermott, Zachary W Bent, Francesca Meschi, Nikola O Kondov, Ryan Wilson, Jorge A Bernate, Shawn Gauby, Alex Kindwall, Clara Bermejo, Adrian N Fehr, Adrian Chan, Serge Saxonov, Kevin D Ness, Benjamin J Hindson & Hanlee P Ji

doi:10.1038/nbt.3432

See also: News and Views by Kitzman


構造が完全なヒトスケールの組織構築物を作製する3Dバイオプリンティングシステム
A 3D bioprinting system to produce human-scale tissue constructs with structural integrity pp312 - 319

Hyun-Wook Kang, Sang Jin Lee, In Kap Ko, Carlos Kengla, James J Yoo & Anthony Atala

doi:10.1038/nbt.3413

See also: News and Views by Pashuck & Stevens


忠実度が高い長期的な皮質神経活動記録のための低侵襲性血管内ステント電極アレイ
Minimally invasive endovascular stent-electrode array for high-fidelity, chronic recordings of cortical neural activity pp320 - 327

Thomas J Oxley, Nicholas L Opie, Sam E John, Gil S Rind, Stephen M Ronayne, Tracey L Wheeler, Jack W Judy, Alan J McDonald, Anthony Dornom, Timothy J H Lovell, Christopher Steward, David J Garrett, Bradford A Moffat, Elaine H Lui, Nawaf Yassi, Bruce C V Campbell, Yan T Wong, Kate E Fox, Ewan S Nurse, Iwan E Bennett, Sébastien H Bauquier, Kishan A Liyanage, Nicole R van der Nagel, Piero Perucca, Arman Ahnood, Katherine P Gill, Bernard Yan, Leonid Churilov, Christopher R French, Patricia M Desmond, Malcolm K Horne, Lynette Kiers, Steven Prawer, Stephen M Davis, Anthony N Burkitt, Peter J Mitchell, David B Grayden, Clive N May & Terence J O'Brien

doi:10.1038/nbt.3428


Letters

CRISPR系成分のウイルス的送達と非ウイルス的送達の併用によるin vivoの治療的ゲノム編集
Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo pp328 - 333

Hao Yin, Chun-Qing Song, Joseph R Dorkin, Lihua J Zhu, Yingxiang Li, Qiongqiong Wu, Angela Park, Junghoon Yang, Sneha Suresh, Aizhan Bizhanova, Ankit Gupta, Mehmet F Bolukbasi, Stephen Walsh, Roman L Bogorad, Guangping Gao, Zhiping Weng, Yizhou Dong, Victor Koteliansky, Scot A Wolfe, Robert Langer, Wen Xue & Daniel G Anderson

doi:10.1038/nbt.3471


マウス新生仔の代謝性肝疾患のCas9による矯正をデュアルAAVシステムが可能にする
A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice pp334 - 338

Yang Yang, Lili Wang, Peter Bell, Deirdre McMenamin, Zhenning He, John White, Hongwei Yu, Chenyu Xu, Hiroki Morizono, Kiran Musunuru, Mark L Batshaw & James M Wilson

doi:10.1038/nbt.3469


触媒活性および触媒不活性CRISPR-Cas9による相同組換えゲノム編集を非対称ドナーDNAで強化する
Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA pp339 - 344

Christopher D Richardson, Graham J Ray, Mark A DeWitt, Gemma L Curie & Jacob E Corn

doi:10.1038/nbt.3481


ヒドロゲルのコンビナトリアルライブラリーは霊長類の異物反応を緩和する材料の同定を可能にする
Combinatorial hydrogel library enables identification of materials that mitigate the foreign body response in primates pp345 - 352

Arturo J Vegas, Omid Veiseh, Joshua C Doloff, Minglin Ma, Hok Hei Tam, Kaitlin Bratlie, Jie Li, Andrew R Bader, Erin Langan, Karsten Olejnik, Patrick Fenton, Jeon Woong Kang, Jennifer Hollister-Locke, Matthew A Bochenek, Alan Chiu, Sean Siebert, Katherine Tang, Siddharth Jhunjhunwala, Stephanie Aresta-Dasilva, Nimit Dholakia, Raj Thakrar, Thema Vietti, Michael Chen, Josh Cohen, Karolina Siniakowicz, Meirigeng Qi, James McGarrigle, Stephen Lyle, David M Harlan, Dale L Greiner, Jose Oberholzer, Gordon C Weir, Robert Langer & Daniel G Anderson

doi:10.1038/nbt.3462


Top

Careers and Recruitment

Towards sustaining a culture of mental health and wellness for trainees in the biosciences pp353 - 355

Jessica W Tsai & Fanuel Muindi

doi:10.1038/nbt.3490

Addressing the mental health of graduate and postdoctoral trainees in the biosciences will substantially benefit the scientific community at large.


People

People p356

doi:10.1038/nbt.3512


Top